NCT03539393

Fremanezumab Managed Access Program for Pediatric Patients

AVAILABLEEXPANDED_ACCESS

Trial Details

Contact

Preventive Treatment of Migraine

Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist approved for the acute treatment of migraine …

Canoga Park, United StatesEst. completion Sep 12, 2028

Migraine

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache,…

Huntsville, United StatesEst. completion May 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.